Cas:52431-30-8 2,5-DIBROMO-3,4-DINITROTHIOPHENE manufacturer & supplier

We serve Chemical Name:2,5-DIBROMO-3,4-DINITROTHIOPHENE CAS:52431-30-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,5-DIBROMO-3,4-DINITROTHIOPHENE

Chemical Name:2,5-DIBROMO-3,4-DINITROTHIOPHENE
CAS.NO:52431-30-8
Synonyms:2,5-DIBROMO-3,4-DINITROTHIOPHENE;Thiophene, 2,5-dibromo-3,4-dinitro-;MFCD00015537
Molecular Formula:C4Br2N2O4S
Molecular Weight:331.927
HS Code:2934999090

Physical and Chemical Properties:
Melting point:137°C
Boiling point:341.2±37.0 °C at 760 mmHg
Density:2.5±0.1 g/cm3
Index of Refraction:1.717
PSA:119.88000
Exact Mass:329.794525
LogP:2.22

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 2,5-DIBROMO-3,4-DINITROTHIOPHENE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00015537 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00015537 Use and application,MFCD00015537 technical grade,usp/ep/jp grade.


Related News: Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,�� said Mark Corbett, EVP, Inceptua Medicines Access. 2,5-DIBROMO-3,4-DINITROTHIOPHENE manufacturer Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. 2,5-DIBROMO-3,4-DINITROTHIOPHENE supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. 2,5-DIBROMO-3,4-DINITROTHIOPHENE vendor Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday. 2,5-DIBROMO-3,4-DINITROTHIOPHENE factory As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory��s officials as they are struggling to contain the coronavirus outbreak.